Liver Disease Treatment Market is projected to grow at a CAGR of 5.7% by 2030: Allied

As per the report, the global liver disease treatment industry generated $20.67 billion in 2020, and is projected to garner $36.45 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030.

Key Takeaways:

• The antiviral drugs segment held the lion’s share
• The cancer segment to portray the highest CAGR through 2030
• North America held the largest share

Get Sample Report at: 

https://www.alliedmarketresearch.com/request-sample/388

Major Factors Driving the Growth of Liver Disease Treatment Market:

Rising Prevalence of Liver Diseases:

The increasing prevalence of liver diseases such as hepatitis B and C, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), and hepatocellular carcinoma (HCC) is a major driver of market growth.

• • Changing lifestyle habits like unhealthy diet, excessive alcohol consumption, and lack of physical activity.
  • Growing prevalence of obesity and type 2 diabetes, which are major risk factors for NAFLD.
  • Insufficient access to clean water and sanitation facilities, contributing to the spread of hepatitis viruses.

Technological Advancements:

Continuous advancements in diagnostic tools and treatment modalities are driving the adoption of new and more effective therapies for liver diseases. This includes:

• • Development of non-invasive diagnostic tests for early detection and staging of liver diseases.
  • Advancements in antiviral therapies for hepatitis B and C.
  • Development of new drugs and therapies for NAFLD and HCC.
  • Improved surgical techniques for liver transplantation.

Market Segmentation:

Covid-19 scenario:

• The Covid-19 outbreak has a moderate impact due to decline in need for drugs that are used in liver treatment, limited availability of medical care, and shortage of healthcare staff.
• The rise in burden of Covid-19 related hospitalization negatively affected the healthcare sector.
• On the contrary, the research studies and activities such as clinical trials for safety and efficacy for treatment of liver diseases boosted the demand for liver disease treatment.

Request for Customization(Get a 20% Discount): 

https://www.alliedmarketresearch.com/request-for-customization/388

Regional Growth Dynamics:

By region, the market across North America held the largest share in 2020, accounting for more than two-fifths of the market, due to rise in geriatric population, adoption of advanced technologies, robust R&D infrastructure for life science researchers, and improved liver disease treatment. However, the global liver disease treatment market across Asia-Pacific is expected to manifest the highest CAGR of 7.8% during the forecast period, owing to rise in liver diseases, increase in public-private investments, and government support for pharmaceutical and biotechnology R&D.

Major market players

• AbbVie Inc.
• Astellas Pharma Inc.
• Abbott Laboratories
• Eli Lilly and Company
• Bristol Myers Squibb
• Emergent BioSolutions (Cangene bioPharma)
• F. Hoffman-LA Roche
• Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
• Gilead Sciences, Inc.
• Viatris Inc.

Buy this Premium Research Report (Get a 20% Discount) : 

https://www.alliedmarketresearch.com/purchase-enquiry/388

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Market Dynamics and Transformations

Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements

Trending Reports in Healthcare Industry (Book Now with 20% Discount):

Intravenous Immunoglobulin (IVIG) Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

COPD and Asthma Devices Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

Nerve Repair and Regeneration Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

Epigenetics Market – Global Opportunity Analysis and Industry Forecast, 2019–2028